logo
Should You Buy FLY Stock after the Firefly Aerospace IPO?

Should You Buy FLY Stock after the Firefly Aerospace IPO?

Yahoo3 days ago
The IPO market has been hot this year with companies like Circle (CRCL) and CoreWeave (CRWV) making blockbuster debuts. The latest to join this list is Firefly Aerospace (FLY), a space and defense technology company.
Closing at $60.35 on Aug. 7, much above its expected IPO price range of $41 to $43, shares of the company have corrected to trade near $54 currently. Thus, the question remains whether investors should look beyond the volatility of the share price and add Firefly to their portfolios. Let's find out.
More News from Barchart
Tesla Is Axing Its Dojo Supercomputer Plans. What Does That Mean for TSLA Stock Here?
Dear CoreWeave Stock Fans, Mark Your Calendars for August 14
This High-Yield (7%) Dividend Stock Is Down Significantly in 2025. Should You Buy the Dip?
Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now!
About Firefly Aerospace
Founded in 2014, Firefly develops small- to medium-lift rockets, lunar landers, and on-orbit infrastructure. Its mission is to make space missions affordable, reliable, and end-to-end, spanning Earth launch to lunar surface operations.
Firefly counts some key defense contractors such as L3Harris (LHX), Northrop Grumman (NOC), and Lockheed Martin (LMT) as its partners.
Increasing Revenues, Widening Losses
Firefly has seen its revenues multiply but losses widen as well over the past year.
For the quarter ended March 31, 2025, Firefly's revenues stood at $55.86 million. This was almost 7 times higher than the previous year's figure of $8.32 million. Spacecraft solutions revenue surged to $50.69 million from $7.01 million in the prior year, and launch revenue of $5.17 million was much higher than the prior year's $1.30 million as well.
In 2024, the company reported revenues of $60.79 million for the full year, up from $55.23 million in 2023.
Net losses widened to $60.09 million in the quarter from $52.77 million in the year-ago period. On a per stock basis, the losses were at $1.65 compared to $1.43 in the previous year. 2024 saw the company report losses of $231.13 million compared to $135.46 million in 2023.
Coming to its backlog, a key indicator of the demand for a company's solutions, it stood at $1.12 billion at the end of March 31, 2025. This was double the previous year's figure of $559.37 million.
Net cash flow from operating activities remained negative at $56.53 million for the quarter, lower than the previous year's $60.58 million outflow. Overall, Firefly's cash balance at the end of the quarter stood at $176.88 million, which was much higher than its short-term debt levels of about $8 million.
Does Firefly Have The Wings to Fly High?
The sky in which Firefly wishes to spread its wings is quite large. Overall, consulting major McKinsey sees space to be a whopping $1.8 trillion opportunity.
But the moot question is: Is Firefly's wings big enough?
The company's portfolio is anchored by two primary launch vehicles, Alpha and Eclipse. Eclipse, developed in collaboration with Northrop Grumman, is capable of carrying payloads of about 16,000 kgs, while Alpha supports payloads of about 1,000 kgs. Beyond launch services, revenue streams are also derived from its spacecraft solutions segment. This includes the Blue Ghost Lander, designed for lunar surface missions, and Elytra, intended for applications such as space domain awareness and other mission-critical activities.
Notably, the addressable market for these offerings is expanding rapidly, propelled by growing demand for satellites serving both commercial and defense purposes. Growth is also underpinned by renewed strategic interest in defense capabilities in space and an accelerating push toward broader space exploration initiatives. These include potential ventures in extraterrestrial resource extraction and space-based energy generation.
Firefly has also positioned itself prominently within the space industry by claiming the first successful commercial lunar landing. The company maintains active contractual relationships with NASA, the U.S. Space Force, and multiple defense entities. Further, product development efforts are also advancing, with Elytra, co-developed with Lockheed Martin, envisioned as a reusable vehicle. Preparations are underway for its inaugural mission, planned as a test flight within the current year. In parallel, the company is developing Ocula, a lunar imaging service designed to assist in identifying suitable landing sites and mapping mineral resources on the Moon's surface.
However, competition remains fierce in this domain with cash-rich names like Elon Musk's SpaceX and Amazon's (AMZN) Project Kuiper in the fray along with direct competitors such as Rocket Labs (RKLB) and Intuitive Machines (LUNR). Further, space is a capital-intensive industry where the margin of error is minuscule. Thus, any product failure exposes the company to a significant decline.
The Bottom Line on FLY Stock
Firefly Aerospace's impressive IPO and rapidly growing revenues highlight its strong positioning. However, widening losses, steep competition from industry giants, and the high-risk, capital-intensive nature of the space industry mean the stock may face turbulence ahead.
Investors will need to weigh its long-term growth potential against near-term financial volatility.
On the date of publication, Pathikrit Bose did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
擷取數據時發生錯誤
登入存取你的投資組合
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CRWV Stock Crashes Post Q2 Earnings: Stay Invested or Make an Exit?
CRWV Stock Crashes Post Q2 Earnings: Stay Invested or Make an Exit?

Yahoo

timean hour ago

  • Yahoo

CRWV Stock Crashes Post Q2 Earnings: Stay Invested or Make an Exit?

CoreWeave, Inc. CRWV stock has declined 33.1% since reporting second-quarter 2025 earnings on Aug. 12. The company reported explosive revenue growth and impressive backlog numbers amid the AI infrastructure boom. Image Source: Zacks Investment Research However, investors likely got unnerved by the company's aggressive expansion strategy, high leverage and near-term profitability, leading to a sell-off. This recent slump is bound to raise an inevitable question: Is it still worth holding, or is making an exit the smarter choice? Let's unpack the company's recent results and the long-term prospects. CRWV's Q2 Earnings Snapshot Revenues in the second quarter were a record $1.2 billion, which beat the Zacks Consensus Estimate by 12.5% and jumped 207% year over year. The top-line performance was driven by demand for AI training and inference workloads, which continue to grow at breakneck speed, as businesses increasingly view AI as a strategic pivot. CoreWeave recorded a series of major achievements, securing customer wins across AI labs, hyperscalers and enterprises like Hippocratic AI, Hologen, BT Group, Cohere, LG CNS, Mistral, Moonvalley, Novel and Woven by Toyota. Highlights included a $4 billion expansion with OpenAI, adding to the previously announced $11.9 billion deal and onboarding of a new hyperscaler customer that expanded within the quarter. Partnerships with Jane Street, Morgan Stanley, and Goldman Sachs are also noteworthy. The company's market position is further reinforced by its $30.1 billion contracted backlog, up $4 billion from the first quarter and doubling year to date. Adjusted operating income was $200 million, up 134% year over year, while adjusted operating margin was 16%, down from 22%. Adjusted EBITDA was $753.2 million compared with $249.8 million in the prior-year quarter. CoreWeave also deployed NVIDIA GB200 NVL72 and HGX B200 systems at scale, integrated into its 'Mission Control' for reliability and performance. It also expanded object storage offerings with automatic tiering and launched new offerings like CoreWeave and Weights & Biases Inference service. The new inference service supports a research-friendly API for OpenAI's new open-source model, Kimi K2, Meta's Llama 4, DeepSeek and QnA3. It is investing in SUNK (Slurm on Kubernetes) for large AI labs and enterprises and is now offering support for third-party storage systems (VAST, WEKA, IBM Spectrum Scale, DDN and Pure Storage) integrated into its technology stack with large-scale production deployments. CRWV had nearly 470 megawatts (MW) of active power and contracted power of 2.2 gigawatts (GW) at the quarter-end. With over 900 MW of active power targeted by year-end, CRWV is positioning itself as a top-tier provider capable of meeting the needs of large-scale AI training and inference workloads. Key projects include a $6 billion data center investment in Lancaster, PA and another data center in Kenilworth, New Jersey, through a joint venture with Blue Owl. Management has raised 2025 revenue guidance to $5.15–$5.35 billion compared $4.9 billion to $5.1 billion projected earlier, citing accelerating demand and a robust pipeline. Why the Stock Dropped: A Look at Bearish Undercurrents CoreWeave's growth strategy heavily depends on massive capital expenditures, with the second quarter capex coming in at $2.9 billion, an increase of $1 billion from the last quarter. The full-year guidance was reaffirmed at $20-$23 billion. CRWV expects capex for the third quarter to be $2.9 billion and $3.4 billion. Higher capex can be a concern if revenues do not keep up the required pace to sustain such high capital intensity, especially in a macro environment where AI demand cycles could fluctuate due to competitive pricing and regulatory changes. CoreWeave's aggressive data center buildout is being funded in large part by debt. It has raised a staggering $25 billion in debt and equity since 2024. Interest expense surged to $267 million compared with $67 million a year ago. For the third quarter, it expects interest expenses to be between $350 million and $390 million, owing to high leverage. Higher interest expenses can exert pressure on the adjusted net income and potentially affect free cash flow generation and undermine near-term profitability. CRWV posted a net loss of $291 million and an adjusted net loss of $131 million, primarily due to heavy interest expenses. CRWV also anticipates stock-based compensation to remain slightly higher in 2025 for the grants issued pertaining to the IPO. CRWV expects adjusted operating income between $160 million and $190 million (down from $200 million in the second quarter) for the current quarter due to the ramping of capacity to meet demand. Moreover, there is intense scrutiny surrounding its Core Scientific acquisition. Both acquisition and large data center projects entail execution and integration risks. Delays or any operational missteps could impact top and bottom-line numbers. Though it raised revenue guidance, adjusted operating income guidance remains unchanged at $800-$830 million for the year, suggesting rising costs will offset some of the revenue gains. CRWV Faces Intense Competition Moreover, CoreWeave faces tough competition in the AI cloud infrastructure space, which boasts behemoths like Amazon AMZN and Microsoft MSFT and other players like Nebius NBIS. Amazon Web Services and Microsoft's Azure cloud platform together dominate more than half of the cloud infrastructure services market, and are now aggressively moving into AI infrastructure. Microsoft's exclusive partnership with OpenAI gives Azure cloud the priority to access leading AI models like GPT-5, while AMZN is ramping up investment to build its technology infrastructure, primarily related to AWS and for custom silicon like Trainium. Nebius is another upcoming AI hyperscaler with hyper revenue growth of 625% in the last reported quarter. It plans to secure 220 megawatts of connected power (either active or ready for GPU deployment) and this also includes data centers in New Jersey and Finland. The company is also finalizing two new large-scale greenfield sites in the United States. NBIS plans to build out over 1 gigawatt of power capacity by 2026. Customer concentration is another major risk. CoreWeave's 77% of total revenues in 2024 came from the top two customers. This is a serious concern, especially if the client migrates, as the revenue impact could be material. Apart from this evolving trade policy, macro uncertainty and volatility remain additional headwinds. Image Source: Zacks Investment Research Given these aforementioned headwinds, there has been a downward revision for CRWV's earnings estimates in the past seven days. Lofty Valuation for CRWV Valuation-wise, CoreWeave seems overvalued, as suggested by the Value Score of F. In terms of Price/Book, CRWV shares are trading at 25.06X, way higher than the Internet Software Services industry's ratio of 7.09X, but it could mean more risk than opportunity. Image Source: Zacks Investment Research Conclusion: Offload CRWV Stock For now, CRWV remains a high-risk, high-reward AI infrastructure play. The company's explosive growth and robust backlog are compelling, but near-term risks are substantial. CoreWeave's heavy customer concentration and ballooning capex pose risk, especially if revenues fall short. Elevated interest expenses and continued dilution from stock-based comp add further pressure on margins. Tremendous competition from Azure, AWS and Google Cloud and stretched valuations are other concerns. With a Zacks Rank #4 (Sell), investors would be better off if they offloaded CRWV from their portfolios. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (AMZN) : Free Stock Analysis Report Microsoft Corporation (MSFT) : Free Stock Analysis Report Nebius Group N.V. (NBIS) : Free Stock Analysis Report CoreWeave Inc. (CRWV) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

CoreWeave Crashes 46% After Lockup--Is This the AI Bargain of the Year or a Falling Knife?
CoreWeave Crashes 46% After Lockup--Is This the AI Bargain of the Year or a Falling Knife?

Yahoo

timean hour ago

  • Yahoo

CoreWeave Crashes 46% After Lockup--Is This the AI Bargain of the Year or a Falling Knife?

CoreWeave's (NASDAQ:CRWV) post-IPO honeymoon may be ending. After skyrocketing more than fourfold by mid-June, the stock has come back to earthfalling 46% from its June 20 peak. The trigger? Over 80% of Class A shares just became eligible for sale as the IPO lockup expired. That timing came two days after CoreWeave's second earnings report, which revealed a wider-than-expected loss despite a raised 2025 revenue forecast. The stock has already dropped 33% this week alone, with analysts flagging the potential for more downside as early investors head for the exit. Warning! GuruFocus has detected 5 Warning Signs with CRWV. The selloff could create both risk and opportunity. CoreWeave now trades at a roughly $49 billion market cap, down from a June high of $88 billion. Its free floatpreviously under 15%could expand significantly as insiders begin selling. That's likely what spooked the market, according to Roundhill CEO Dave Mazza, who called it a challenging, even confusing setup. Citi's Tyler Radke echoed that sentiment, warning of short-term pressure but suggesting that a more liquid float might attract new buyers. Meanwhile, Nvidia (NASDAQ:NVDA)CoreWeave's key AI chip supplierisn't going anywhere. It actually increased its stake in Q2 to 6.5%, now worth about $2.4 billion. The long-term bull case hasn't vanished. CoreWeave is still spending aggressivelyup to $23 billion this yearto meet rising AI demand, and counts Microsoft as its largest customer. But execution risk is climbing, especially with its all-stock acquisition of Core Scientific looming. Hedge funds like Magnetar and Coatue may opt to ease out slowly to avoid triggering further panic. D.A. Davidson's Gil Luria has a $36 price target, implying over 60% downside from recent levels. Whether this marks a healthy reset or the beginning of a deeper unwind depends on who shows up to buyif anyone does. This article first appeared on GuruFocus.

CRWV and RBLX: Cathie Wood Invests Over $27 Million in Tech Stocks
CRWV and RBLX: Cathie Wood Invests Over $27 Million in Tech Stocks

Business Insider

time4 hours ago

  • Business Insider

CRWV and RBLX: Cathie Wood Invests Over $27 Million in Tech Stocks

Popular investor Cathie Wood 's ARK Invest ETFs disclosed their latest trades for Friday, August 15, highlighting major bets on Roblox (RBLX) and CoreWeave (CRWV). Together, the two tech buys amounted to nearly $27.8 million, signaling ARK's conviction in gaming platforms and AI-powered cloud computing. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The largest trade of the day was the purchase of 125,799 Roblox shares, spread across three ARK funds, namely, ARK Innovation ETF (ARKK), ARK Next Generation Internet ETF (ARKW), and ARK Fintech Innovation ETF (ARKF), valued at $15.8 million. The buy continues a trend, as ARK has steadily increased its stake in the gaming platform throughout the past week. Another notable move was the addition of 120,229 CoreWeave shares through the ARKW ETF, worth nearly $12 million. CoreWeave has emerged as a rising name in cloud and high-performance computing, offering infrastructure critical to AI development. ARK's growing position signals strong confidence in CoreWeave's potential to become a key player in the next phase of computing. ARK Expands Its Biotech Bets on Friday ARK continued to invest in healthcare names, with ARKK purchasing 165,024 shares of CRISPR Therapeutics (CRSP) valued at $9.7 million. The firm also added 456,045 shares of Intellia Therapeutics (NTLA) worth about $5 million, along with 417,397 shares of Twist Bioscience (TWST) valued at $12 million. These trades show ARK's focus on gene-editing and synthetic biology companies, even as biotech stocks remain volatile. On the sell side, ARK's ARKW ETF offloaded 190,396 shares of Genius Sports (GENI) for about $2.5 million. Notably, the stock has gained over 49% year-to-date. Let's take a brief look at how all these stocks perform on .

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store